Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Revolution Medicines (RVMD) Return on Invested Capital (2020 - 2024)

Revolution Medicines (RVMD) has 5 years of Return on Invested Capital data on record, last reported at 0.36% in Q4 2024.

  • For Q4 2024, Return on Invested Capital rose 1.0% year-over-year to 0.36%; the TTM value through Dec 2024 reached 0.36%, up 1.0%, while the annual FY2024 figure was 0.34%, 5.0% up from the prior year.
  • Return on Invested Capital reached 0.36% in Q4 2024 per RVMD's latest filing, up from 0.36% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.2% in Q2 2021 and bottomed at 0.42% in Q3 2022.
  • Average Return on Invested Capital over 5 years is 0.31%, with a median of 0.31% recorded in 2021.
  • Peak YoY movement for Return on Invested Capital: fell -17bps in 2022, then grew 1bps in 2023.
  • A 5-year view of Return on Invested Capital shows it stood at 0.23% in 2020, then fell by -14bps to 0.26% in 2021, then tumbled by -65bps to 0.42% in 2022, then grew by 14bps to 0.36% in 2023, then increased by 2bps to 0.36% in 2024.
  • Per Business Quant database, its latest 3 readings for Return on Invested Capital were 0.36% in Q4 2024, 0.36% in Q4 2023, and 0.41% in Q3 2023.